Deltawave CPAP Interface Mask
REMSleep Holdings, Inc. (OTC PINK: RMSL) has filed a 510K submission for its DeltaWave CPAP pillows interface mask. The submission, numbered K212087, was received on July 6, 2021. This marks a significant step for the company in advancing its product offerings in the sleep treatment market. The DeltaWave Nasal Pillows System aims to enhance patient comfort and efficacy in CPAP therapy. The press release includes forward-looking statements that caution against placing undue reliance on future projections and highlights potential risks associated with financing, competition, and regulatory matters.
- Filed 510K submission for DeltaWave CPAP pillows interface mask; significant step in product development.
- Potential for enhanced patient comfort and therapy efficacy with new product offering.
- Forward-looking statements indicate potential risks such as insufficient financing and competition.
Tampa, FL, July 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC PINK: RMSL) is pleased to announce the company has filed the 510K submission for its Deltawave CPAP pillows interface mask.
Submission Number: K212087 Received: 7/6/2021
Applicant: REM Sleep Holdings Inc. Device: DeltaWave Nasal Pillows System
Forward-looking statements.
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company's business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. No information in this press release should be construed as any indication whatsoever of the Company's future revenues, results of operations or stock price. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Tom Wood
twood@remsleep.com
FAQ
What is the recent development regarding RMSL?
When was the 510K submission for RMSL filed?
What is the significance of the DeltaWave CPAP pillows system for RMSL?
What are the potential risks mentioned in RMSL's press release?
